资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Synthetic Antibodies neutralize SARS-CoV-2 infection of mammalian cells

Clinical Trial. 2020-06;

Feng-Cai Zhu , Yu-Hua Li , Xu-Hua Guan , Li-Hua Hou , Wen-Juan Wang , Jing-Xin Li , Shi-Po Wu , Bu-Sen Wang , Zhao Wang , Lei Wang , Si-Yue Jia , Hu-Dachuan Jiang , Ling Wang , Tao Jiang , Yi Hu , Jin-Bo Gou , Sha-Bei Xu , Jun-Jie Xu, Xue-Wen Wang, Wei Wang , Wei Chen

Products/Services Used	Details	Operation
Gene Synthesis	synthesized by Genscript. cDNAencoding human ACE2 was obtained from MGC clone 47598.	Get A Quote

摘要

Background: A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the spike glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain.